Case Report
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 6, 2020; 8(11): 2387-2391
Published online Jun 6, 2020. doi: 10.12998/wjcc.v8.i11.2387
Ataxia-telangiectasia complicated with Hodgkin's lymphoma: A case report
Xiao-Ling Li, Yi-Lin Wang
Xiao-Ling Li, Yi-Lin Wang, Department of Pediatrics (III), The Linyi People’s Hospital, Linyi 276000, Shandong Province, China
Author contributions: Li XL conceived of and designed the study, performed the final data analyses, and wrote the manuscript; Wang YL drafted the initial manuscript and carried out the initial analyses.
Informed consent statement: The patient’s guardian agreed to the genetic test and signed a written informed consent form.
Conflict-of-interest statement: The authors declare no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yi-Lin Wang, MD, Assistant Professor, Chief Physician, Department of Pediatrics (III), The Linyi People’s Hospital, No. 27, Jiefang Road, Linyi 276000, Shandong Province, China. lxl801527@hotmail.com
Received: March 2, 2020
Peer-review started: March 2, 2020
First decision: April 22, 2020
Revised: May 9, 2020
Accepted: May 16, 2020
Article in press: May 16, 2020
Published online: June 6, 2020
Processing time: 97 Days and 20.9 Hours
Core Tip

Core tip: Ataxia-telangiectasia (AT) is a rare, autosomal recessive, multisystem disorder. Homozygous or compound heterozygous mutations of the ATM gene is the pathogenic factor and there is no specific treatment for AT. Through this study of a case of AT complicated with Hodgkin's lymphoma, it is suggested that clinicians should strengthen their understanding of AT diseases.